Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19Ryan S. Thwaites, Thilipan Thaventhiran, Emma Bergstrom et al.|Science Immunology|2021Cited by 259
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Meera Chand, Shubha Talwar et al.|EBioMedicine|2022Cited by 121
Nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccinationFelicity Liew, Peter Openshaw, Shubha Talwar et al.|medRxiv|2022Cited by 18
Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19Ryan S. Thwaites, Peter Openshaw, Ashley Sanchez Sevilla Uruchurtu et al.|medRxiv|2020Cited by 9
Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19Jasmin Sidhu, Lynn Maslen, Matthew K. Siggins et al.|The Journal of Infectious Diseases|2023Cited by 9